Pharmaceutical
Biopharmaceutical
Biotechnology

ImmunoGen

$3.53
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.16 (-4.21%) As of 3:54 PM EDT today

Why Robinhood?

You can buy or sell ImmunoGen and other stocks, options, ETFs, and crypto commission-free!

About IMGN

ImmunoGen, Inc. engages in the discovery and development of antibody-drug conjugates to improve outcomes for cancer patients. Its pipeline includes Mirvetuximab Soravtansine, IMGN632, IMGC936, and IMGN151. Read More The company was founded in March 1981 and is headquartered in Waltham, MA. The listed name for IMGN is ImmunoGen, Inc. Common Stock.

CEO
Mark J. Enyedy
Employees
75
Headquarters
Waltham, Massachusetts
Founded
1981
Market Cap
621.37M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
2.41M
High Today
$3.63
Low Today
$3.48
Open Price
$3.63
Volume
1.02M
52 Week High
$7.07
52 Week Low
$1.95

Collections

Pharmaceutical
Biopharmaceutical
Biotechnology
Therapy
Cancer Prevention
Technology
Health
US

IMGN Earnings

-$0.33
-$0.21
-$0.09
$0.03
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Estimated
— per share
Actual
Expected Oct 30, Pre-Market

You May Also Like

HBNC
HJLIW
MAAX
FMC
GVI
OKTA
ABTX
HALO
MGLN
GWB
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.
Buy IMGN
Market Price
$3.53
Commissions
$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell ImmunoGen stock and options commission-free.
LearnBlogCareersHelpLog InSign Up